We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Glaxo Eyes Court Ruling On Seritide Patent

Law360 (March 11, 2004, 12:00 AM EST) -- A U.K. court is expected to decide later this month on the validity of a key patent on GlaxoSmithKline’s asthma drug Seritide.

Indian generic drugmaker Cipla has challenged a key U.K. patent on the drug, which expires in 2013, on the grounds of obviousness.

Cipla, along with Neolab — its distributor in the U.K. —filed a case in a London court in the first quarter of 2003, seeking revocation of one of the patents on Seretide, a combination of asthma drugs fluticasone and salmeterol.

GlaxoSmithKline also...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.